z-logo
Premium
T3SS effector ExoY reduces inflammasome‐related responses by suppressing bacterial motility and delaying activation of NF‐κB and caspase‐1
Author(s) -
Jeon Jisu,
Kim YongJae,
Shin Heesung,
Ha UnHwan
Publication year - 2017
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/febs.14199
Subject(s) - inflammasome , effector , microbiology and biotechnology , biology , type three secretion system , pyroptosis , immunology , inflammation , mutant , gene , biochemistry
Type III‐secreted effectors are essential for modulating host immune responses during the pathogenesis of Pseudomonas aeruginosa infections. Little is known about the impact of one of the effectors, ExoY, on inflammasome activation, which results in IL‐1β production and pyroptotic cell death. In this study, we found that transcriptional expression of Il‐1β was induced to a lesser extent in response to an exoY ‐harboring strain than to a deleted mutant. This suppressive effect of ExoY was verified by complementation assay as well as by direct translocation of exoY into host cells. In addition to the production of IL‐1β, pyroptotic cell death was also diminished in response to an exoY ‐harboring strain. These inflammasome responses were mediated by the adenylate cyclase activity of ExoY, which plays a role in delaying the activation of NF‐κB and caspase‐1, a key component of inflammasome‐mediated responses. Moreover, the negative effects of ExoY on these responses were in part conferred by the suppression of bacterial motility, which could reduce the degree of bacterial contact with cells. Together, these results demonstrate that the adenylate cyclase activity of P. aeruginosa ExoY can reduce inflammasome‐related responses by influencing both the host and the bacterium itself by delaying the activation of inflammatory pathways and suppressing bacterial motility.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here